OPKO Health EPS - Earnings per Share 2010-2025 | OPK
OPKO Health eps - earnings per share from 2010 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| OPKO Health Annual EPS | |
|---|---|
| 2024 | $-0.08 |
| 2023 | $-0.25 |
| 2022 | $-0.46 |
| 2021 | $-0.05 |
| 2020 | $0.05 |
| 2019 | $-0.53 |
| 2018 | $-0.27 |
| 2017 | $-0.55 |
| 2016 | $-0.10 |
| 2015 | $-0.06 |
| 2014 | $-0.41 |
| 2013 | $-0.32 |
| 2012 | $-0.11 |
| 2011 | $-0.01 |
| 2010 | $-0.08 |
| 2009 | $-0.15 |
| OPKO Health Quarterly EPS | |
|---|---|
| 2025-03-31 | $-0.10 |
| 2024-12-31 | $0.02 |
| 2024-09-30 | $0.03 |
| 2024-06-30 | $-0.01 |
| 2024-03-31 | $-0.12 |
| 2023-12-31 | $-0.09 |
| 2023-09-30 | $-0.11 |
| 2023-06-30 | $-0.03 |
| 2023-03-31 | $-0.02 |
| 2022-12-31 | $-0.13 |
| 2022-09-30 | $-0.11 |
| 2022-06-30 | $-0.14 |
| 2022-03-31 | $-0.08 |
| 2021-12-31 | $-0.11 |
| 2021-09-30 | $0.04 |
| 2021-06-30 | $-0.03 |
| 2021-03-31 | $0.05 |
| 2020-12-31 | $0.05 |
| 2020-09-30 | $0.04 |
| 2020-06-30 | $0.05 |
| 2020-03-31 | $-0.09 |
| 2019-12-31 | $-0.18 |
| 2019-09-30 | $-0.11 |
| 2019-06-30 | $-0.10 |
| 2019-03-31 | $-0.14 |
| 2018-12-31 | $-0.13 |
| 2018-09-30 | $-0.05 |
| 2018-06-30 | $-0.01 |
| 2018-03-31 | $-0.08 |
| 2017-12-31 | $-0.39 |
| 2017-09-30 | $-0.06 |
| 2017-06-30 | $-0.04 |
| 2017-03-31 | $-0.06 |
| 2016-12-31 | $-0.07 |
| 2016-09-30 | $-0.03 |
| 2016-06-30 | $0.02 |
| 2016-03-31 | $-0.02 |
| 2015-12-31 | $0.11 |
| 2015-09-30 | $0.18 |
| 2015-06-30 | $-0.09 |
| 2015-03-31 | $-0.26 |
| 2014-12-31 | $-0.13 |
| 2014-09-30 | $-0.11 |
| 2014-06-30 | $-0.06 |
| 2014-03-31 | $-0.11 |
| 2013-12-31 | $-0.03 |
| 2013-09-30 | $-0.17 |
| 2013-06-30 | $-0.01 |
| 2013-03-31 | $-0.11 |
| 2012-12-31 | $-0.01 |
| 2012-09-30 | $-0.03 |
| 2012-06-30 | $-0.04 |
| 2012-03-31 | $-0.03 |
| 2011-12-31 | $0.06 |
| 2011-09-30 | $-0.03 |
| 2011-06-30 | $-0.02 |
| 2011-03-31 | $-0.02 |
| 2010-12-31 | $0.00 |
| 2010-09-30 | $-0.03 |
| 2010-06-30 | $-0.03 |
| 2010-03-31 | $-0.02 |
| 2009-12-31 | $-0.03 |
| 2009-09-30 | $-0.04 |
| 2009-06-30 | $-0.03 |
| 2009-03-31 | $-0.05 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.071B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $187.241B | 82.01 |
| Thermo Fisher Scientific (TMO) | United States | $156.717B | 18.96 |
| Edwards Lifesciences (EW) | United States | $44.271B | 29.03 |
| Alcon (ALC) | Switzerland | $43.692B | 29.53 |
| IDEXX Laboratories (IDXX) | United States | $42.156B | 48.44 |
| DexCom (DXCM) | United States | $32.541B | 50.30 |
| IQVIA Holdings (IQV) | United States | $27.478B | 15.39 |
| Mettler-Toledo (MTD) | United States | $24.793B | 29.49 |
| STERIS (STE) | Ireland | $23.682B | 26.08 |
| Waters (WAT) | United States | $20.593B | 29.06 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.749B | 0.00 |
| Hologic (HOLX) | United States | $14.391B | 15.64 |
| Sysmex ADR (SSMXY) | Japan | $10.512B | 29.82 |
| Penumbra (PEN) | United States | $9.810B | 76.99 |
| Masimo (MASI) | United States | $9.055B | 33.40 |
| Globus Medical (GMED) | United States | $8.231B | 19.61 |
| Glaukos (GKOS) | United States | $5.665B | 0.00 |
| Teleflex (TFX) | United States | $5.412B | 8.93 |
| TransMedics (TMDX) | United States | $4.833B | 105.06 |
| Integer Holdings (ITGR) | United States | $4.188B | 21.94 |
| PROCEPT BioRobotics (PRCT) | United States | $3.437B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.546B | 15.16 |
| Veracyte (VCYT) | United States | $2.187B | 30.69 |
| Nihon Kohden (NHNKY) | Japan | $2.115B | 24.25 |
| Elekta AB (EKTAY) | Sweden | $1.972B | 17.72 |
| Alphatec Holdings (ATEC) | United States | $1.715B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.435B | 0.00 |
| Artivion (AORT) | United States | $1.241B | 116.20 |
| Pulse Biosciences (PLSE) | United States | $1.125B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.997B | 5.30 |
| Beta Bionics (BBNX) | United States | $0.829B | 0.00 |
| SiBone (SIBN) | United States | $0.802B | 0.00 |
| IRadimed (IRMD) | United States | $0.763B | 38.72 |
| RxSight (RXST) | United States | $0.606B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.570B | 13.36 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.570B | 8.86 |
| Delcath Systems (DCTH) | United States | $0.556B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.537B | 0.00 |
| AxoGen (AXGN) | United States | $0.463B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.446B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.443B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.388B | 0.00 |
| NeuroPace (NPCE) | United States | $0.388B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.360B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.354B | 9.41 |
| Pacific Biosciences Of California (PACB) | United States | $0.348B | 0.00 |
| 908 Devices (MASS) | United States | $0.261B | 0.00 |
| Neuronetics (STIM) | United States | $0.251B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.13 |
| Sight Sciences (SGHT) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.216B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.185B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.183B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.165B | 0.00 |
| LENSAR (LNSR) | United States | $0.153B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.138B | 0.00 |
| Accuray (ARAY) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.113B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.084B | 51.00 |
| EnVVeno Medical (NVNO) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.22 |